Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China · Delayed Price · Currency is CNY 17.86
+0.25 (1.42%)
Sep 30, 2026, 3:04 PM CST
SHE:300497 Market Cap
SHE:300497 has a market cap or net worth of 9.62 billion as of October 2, 2026. Its market cap has increased by 80.40% in one year.
Market Cap
9.62B
Enterprise Value
10.75B
Revenue
1.56B
Ranking
n/a
PE Ratio
65.55
Stock Price
17.86
ChartMarket Cap Chart
Since December 22, 2015, SHE:300497's market cap has increased from 1.59B to 9.62B, an increase of 505.14%. That is a compound annual growth rate of 18.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.62B | 18.20% |
| Dec 31, 2025 | 8.14B | 81.18% |
| Dec 31, 2024 | 4.49B | -10.90% |
| Dec 29, 2023 | 5.04B | -29.09% |
| Dec 30, 2022 | 7.11B | -19.99% |
| Dec 31, 2021 | 8.89B | 34.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Cheezheng Tibetan Medicine | 10.99B |
| InventisBio | 10.55B |
| Chengzhi | 10.50B |
| Staidson (Beijing) BioPharmaceuticals | 9.77B |
| Pacific Shuanglin Bio-pharmacy | 9.44B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.41B |
| Chongqing Genrix Biopharmaceutical | 9.28B |
| Chengdu Easton Biopharmaceuticals | 8.88B |